Work

In Reply: Diabetic retinopathy: Screening, prevention, and treatment

Year: 2024

Type: letter

Abstract: We thank Ashley Lim for the comments on our review article.[1][1] We are pleased that readers are interested in our review and appreciate the opportunity to discuss any concerns raised in the letter. We agree that new therapies such as glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-

Source: Cleveland Clinic Journal of Medicine

DOI: 10.3949/ccjm.91c.12002

Authors: David D. Chong, Nikhil Das, Rishi P. Singh

Institutions: Case Western Reserve University, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic Florida

Language: English

Topic: Retinal Diseases and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4404920331

Cites:

Cited by:

Related to: 10